an epigenetic action of this drug combination through histone acetylation and promoter
demethylation.
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author ManuscriptIn mammalian cells, active DNA-demethylation is achieved, at least in part, by a base-excision repair pathway that first requires the conversion of 5mC to thymine (T) throughdeamination (Ooi and Bestor 2008, Zhu, 2009). Recently, human breast cancer cell researchsuggested that DNMT3a and DNMT3b can convert 5mC to T through deamination; theresulting T is then removed by a G/T mismatch base-excision repair pathway (for a reviewsee Zhu, 2009). Indeed, recent studies suggest that in mammalian cells including neurons,DNA-demethylation at promoter genes involved in memory and cognition or neurogenesiscan be achieved by the coupled action of 5mC deamination [i.e., elicited by DNMT3a, 3b,AID (activation induced deaminase), or Apobec (apolipoprotein B RNA editing catalyticcomponent)] and G/T mismatch DNA glycosylation presumably catalyzed by the methylbinding protein-4 (MBD4) (Ma et al. 2009, Kim et al., 2009).It has been proposed that coupling between 5mC deaminase and G/T mismatch DNAglycosylase is favored by the presence of “growth arrest and DNA-damage-inducible protein45 (Gadd45) α and β (Fig. 6). These are small active nuclear acidic proteins that are inducedin neurons by stress or by drugs that increase neuronal activity (Gavin et al., 2010).Recently, it has been reported that electroconvulsive treatment a) induces Gadd45 βexpression, b) increases Gadd 45 β binding to cytosine deaminase or G/T mismatchglycosylase, and c) induces DNA-demethylation at specific gene promoters (i.e., BDNF,Fgf-1) that is abolished in Gadd45 KO mice (Ma et al., 2009). Hence, it is thought thatGadd45 proteins exert a putative regulatory role on DNA-methylation.
Given our data suggesting that subtypes of antipsychotic medications and VPA can
synergistically interact to activate DNA-demethylation (Fig 3 and table 4), we examined the
possibility that VPA and antipsychotic drugs elicit functionally-relevant DNA-
demethylation changes altering the expression or activity of Gadd45 α or β. We found that
in the FC of mice that had been given 70 mg/kg of VPA/three days/twice a day, Gadd45 β
mRNA expression is increased compared to vehicle-treated controls (Fig. 7). Histochemical
studies with specific Gadd45 β antibodies also show that cortical pyramidal neurons of mice
treated with VPA (70 mg/kg/three days) exhibit increased nuclear Gadd45 β expression
compared with vehicle-treated mice (Fig. 8). Moreover, clozapine in a dose that per se
increases Gadd45 β potentiates the action of VPA (Fig. 7). Since these doses of clozapine
and VPA induce promoter-demethylation (Fig. 4), taken together, the data suggest that in
addition to DNMTs, neuronal promoter methylation can be regulated by the activity of a
putative DNA demethylase, which can remove a methyl group from the carbon 5 of C.
Hence, evidence suggests that in neurons, promoter methylation is a dynamic process that
can be altered in response to environmental factors, such as stress, drugs, and various
psychopathologies.
Concluding remarks
Recent breakthroughs in the study of aberrant molecular mechanisms operative in SZ and
BP disorder point to a downregulation in the expression of several genes in GABAergic
DNA methylation and demethylation神经疾病靶点_生物学_自然科学_专业资料。Pharmacological...Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuroph...
et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011; 20: 4786-4796. Rogd...
et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011; 20: 4786-4796. Rogd...
热门文档